Our direct commercial presence in the United States is Helsinn Therapeutics (U.S.), Inc., a fully integrated specialty pharmaceutical company and a key part of the global Helsinn Group, which has 50 years of experience in healthcare. At the core of our U.S. operations is a strong commitment to supportive care, oncology, and the emerging field of dermato-oncology. We offer a comprehensive portfolio of treatments designed to improve patients’ quality of life at every stage of their healthcare journey.
Through close collaboration with key opinion leaders and decision-makers, we remain at the forefront of medical innovation, delivering therapies that meet the unique needs of the U.S. patient population. Supported by a robust sales team, market access professionals, and a dedicated field medical team, we combine expertise in rare diseases and blockbuster brands with a relentless drive for innovation to transform the lives of patients with cancer and chronic conditions.
Agility and scalability are central to our success. Backed by an experienced management team and strategic partnerships, we are equipped to launch and enhance specialty products while adapting swiftly to an ever-changing market landscape.
Our extensive global network of commercial partners is what enables us to reach patients worldwide.
We carefully select our local partners based on a set of criteria including but not limited to shared values, strength of coverage in local markets, and strategic fit of the partnership.
Throughout the product life-cycle, Helsinn works closely with commercial partners and healthcare professionals to provide tailored services ranging from disease education, international marketing, market access activities, regulatory and legal advice, through to field sales and product promotion support.
Helsinn Healthcare SA. All rights reserved. Helsinn Group 2025 ©
Please click ‘Continue to external site’ if you want to continue.
